Danaher Corporation is a U.S.-based global science and technology company focused on life sciences and diagnostics. It develops and supplies instruments, consumables, and software used in research laboratories, bioprocessing, and clinical settings. Its portfolio includes brands such as Cytiva and Pall (bioprocessing and filtration), Beckman Coulter and Cepheid (diagnostics), Leica Microsystems (microscopy), and Integrated DNA Technologies (genomics). Danaher is headquartered in Washington, D.C., and is listed on the NYSE under the ticker DHR.
For the chemical and bioprocess value chain, Danaher provides filtration and separation technologies, chromatography media, single-use assemblies and polymers, process analytics, and lab automation that support the development and manufacture of biologics, vaccines, and advanced therapies. The company applies its Danaher Business System to continuous improvement and has refined its portfolio through acquisitions and divestitures, including the 2023 spin-off of its former Environmental & Applied Solutions businesses into Veralto.